https://european-biotechnology.net/wp-content/uploads/2025/01/Lungen-Image-by-David_SMC-from-Pixabay.png
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-16 14:34:462025-01-16 14:34:46Synairgen raises £18m for Phase 2 INVENT trial of SNG001
https://european-biotechnology.net/wp-content/uploads/2025/01/caplyta_By-Vaccinationist-Wikipedia-1030x385-1.png
385
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-15 08:06:332025-01-15 08:06:33Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion
https://european-biotechnology.net/wp-content/uploads/2025/01/nasal_spray_robin_24-Wikipedia.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-13 14:32:212025-01-13 14:32:21Leyden Labs secures $70M to advance intranasal antibody therapies
https://european-biotechnology.net/wp-content/uploads/2025/01/gr3_lrg-1030x730-1.jpg
730
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-13 08:42:232025-01-13 08:42:23First in vivo CAR gene therapy trial in Europe approved
https://european-biotechnology.net/wp-content/uploads/2025/01/synapse-Image-by-Pete-Linforth-from-Pixabay.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-10 09:56:352025-01-10 09:56:35Angelini Ventures co-leads €20m Series A to advance RNA therapeutics for neurological disorders
https://european-biotechnology.net/wp-content/uploads/2025/01/RNA_Justlight-AdobeStock.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-10 09:54:352025-01-10 09:54:35New RNA company Inverna Therapeutics launched
https://european-biotechnology.net/wp-content/uploads/2025/01/VC_money-1030x686-1.jpg
686
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-09 09:15:042025-01-09 09:15:04USD410m Mega Series A for yet another GLP-1 play?
https://european-biotechnology.net/wp-content/uploads/2025/01/home-img-e1736329767777-1030x488-1.jpg
488
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-09 09:05:412025-01-09 13:02:02Jeito Capital leads $67.5m Series B financing for cardiovascular gene therapy
https://european-biotechnology.net/wp-content/uploads/2025/01/EB_Summer_2019_CRISPR-Babys_123rf-valentinakru-117271512_tg.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-08 15:50:452025-01-09 11:02:03Qiagen joins Newborn genomic screening of NHS
https://european-biotechnology.net/wp-content/uploads/2025/01/wuxi-biologics-buffer-prep-room.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-01-07 16:26:002025-01-08 13:32:02WuXi Biologics Sells Irish Vaccine Site to Merck for $500m
Scroll to top
